Variation in the capacity of these transcription factors to upregulate the melatonergic pathway is of some importance to T1DM pathophysiology, given that melatonin protects and optimizes pancreatic β-cell function and insulin regulation at nM levels [33,52], including via the optimization of mitochondrial function. Here, INS is linked to type 1 diabetes mellitus.